End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 USD | +3.45% | -24.05% | -98.01% |
May. 14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 10 | Liquidation Plan and Disclosure Statement Filed by Acorda Therapeutics, Inc. | CI |
Financials (USD)
Sales 2022 | 119M | Sales 2023 | 118M | Capitalization | 18.74M |
---|---|---|---|---|---|
Net income 2022 | -65M | Net income 2023 | -253M | EV / Sales 2022 | 1.3 x |
Net Debt 2022 | 135M | Net Debt 2023 | 161M | EV / Sales 2023 | 1.53 x |
P/E ratio 2022 |
-0.23
x | P/E ratio 2023 |
-0.07
x | Employees | 102 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.33% |
Latest transcript on Acorda Therapeutics, Inc.
1 day | +3.45% | ||
1 week | -24.05% | ||
Current month | -24.05% | ||
1 month | -65.87% | ||
3 months | -97.80% | ||
6 months | -97.60% | ||
Current year | -98.01% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.3 | +3.45% | 408 |
24-06-06 | 0.29 | -3.33% | 24,794 |
24-06-05 | 0.3 | +7.14% | 51,780 |
24-06-04 | 0.28 | -20.00% | 129,128 |
24-06-03 | 0.35 | -11.39% | 76,313 |
End-of-day quote OTC Markets, June 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-98.01% | 373K | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ACOR.Q Stock